Last updated 9 days ago

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

780 patients around the world
Available in Chile, Brazil, United States
Merck Sharp & Dohme LLC
3Research sites
780Patients around the world
This study is for people with
Lung cancer
Non-small cell lung carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto de Oncologia Saint Gallen
Recruiting
R. Mal. Deodoro, 1139 - Bonfim, Santa Cruz do Sul - RS, 96810-102, Brazil
Centro de Estudios Clínicos SAGA - CECSAGA
Recruiting
Antonio Varas 517, 7500653 Providencia, Región Metropolitana
Oncocentro APYS - Valparaíso
Recruiting
Avenida La Marina 1702, Viña del Mar, Valparaíso
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy